STOCK ALARM
PRO
SA
PRO
News
Screener
Heatmap
Rankings
Signals
Alerts
More
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Boston Scientific Corporation
BSX
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Financials
Analysis
More
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$20B
↑20%
Gross Profit
$14B
↑35%
Operating Income
$4B
↑51%
Net Income
$3B
↑56%
EBITDA
$4B
↓5%
EPS Diluted
1.9
Cost of Revenue
$6B
Gross Margin %
69.0%
R&D Expenses
$2B
SG&A Expenses
$7B
Operating Expenses
$10B
Operating Margin %
19.8%
Interest Expense
$349M
Income Before Tax
$3B
Income Tax Expense
$493M
Net Margin %
14.4%
EPS
2.0
Shares Out (Diluted)
1.5B
Shares Out (Basic)
1.5B
Total Costs & Expenses
$16B
Interest Income
$0
EBITDA Margin %
18.6%
Pre-Tax Margin %
16.9%
Other Income/Expenses
$-586M
Revenue CAGR (5Y)
+15.2%
Margin Trend
improving
Free Cash Flow
$3.7B
Profitability
Profitable
Metric
Dec 21
Dec 22
Dec 23
Dec 24
Dec 25
Revenue
11,888
12,682
↑6.7%
14,240
↑12.3%
16,747
↑17.6%
20,074
↑19.9%
Gross Profit
7,461
7,714
↑3.4%
8,831
↑14.5%
10,267
↑16.3%
13,853
↑34.9%
Operating Income
1,922
1,824
↓5.1%
2,181
↑19.6%
2,635
↑20.8%
3,971
↑50.7%
Net Income
1,040
698
↓32.9%
1,593
↑128.2%
1,854
↑16.4%
2,886
↑55.7%
EBITDA
2,518
2,741
↑8.9%
3,453
↑26.0%
3,938
↑14.0%
3,733
↓5.2%
EPS Diluted
0.69
0.45
↓35.1%
1.07
↑140.6%
1.25
↑16.5%
1.94
↑55.2%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages